These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29981184)

  • 1. Belatacept rescue for delayed kidney allograft function in a patient with previous combined heart-liver transplant.
    Kumar D; Yakubu I; Cooke RH; Halloran PF; Gupta G
    Am J Transplant; 2018 Oct; 18(10):2613-2614. PubMed ID: 29981184
    [No Abstract]   [Full Text] [Related]  

  • 2. Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.
    Adams AB; Goldstein J; Garrett C; Zhang R; Patzer RE; Newell KA; Turgeon NA; Chami AS; Guasch A; Kirk AD; Pastan SO; Pearson TC; Larsen CP
    Am J Transplant; 2017 Nov; 17(11):2922-2936. PubMed ID: 28544101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor-Intolerant Graft Recipients of Kidneys From Extended-Criteria Donors.
    Le Meur Y; Aulagnon F; Bertrand D; Heng AE; Lavaud S; Caillard S; Longuet H; Sberro-Soussan R; Doucet L; Grall A; Legendre C
    Am J Transplant; 2016 Jul; 16(7):2181-6. PubMed ID: 26718625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation.
    Badell IR; Karadkhele GM; Vasanth P; Farris AB; Robertson JM; Larsen CP
    Am J Transplant; 2019 Aug; 19(8):2342-2349. PubMed ID: 30768841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients.
    Wojciechowski D; Chandran S; Vincenti F
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28190259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study.
    Bertrand D; Cheddani L; Etienne I; François A; Hanoy M; Laurent C; Lebourg L; Le Roy F; Lelandais L; Loron MC; Godin M; Guerrot D
    Am J Transplant; 2017 Nov; 17(11):2937-2944. PubMed ID: 28707779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly.
    Vincenti F; Blancho G; Durrbach A; Grannas G; Grinyó J; Meier-Kriesche HU; Polinsky M; Yang L; Larsen CP
    Am J Transplant; 2017 Dec; 17(12):3219-3227. PubMed ID: 28758341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belatacept Conversion in an HIV-Positive Kidney Transplant Recipient With Prolonged Delayed Graft Function.
    Ebcioglu Z; Liu C; Shapiro R; Rana M; Salem F; Florman S; Huprikar S; Nair V
    Am J Transplant; 2016 Nov; 16(11):3278-3281. PubMed ID: 27328903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study.
    Mulvihill MS; Samy KP; Gao QA; Schmitz R; Davis RP; Ezekian B; Leopardi F; Song M; How T; Williams K; Barbas A; Collins B; Kirk AD
    Am J Transplant; 2019 Aug; 19(8):2350-2357. PubMed ID: 30891931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR).
    Leibler C; Matignon M; Moktefi A; Samson C; Zarour A; Malard S; Boutin E; Pilon C; Salomon L; Natella PA; Durrbach A; Robert T; Canoui-Poitrine F; Grimbert P
    Am J Transplant; 2019 Mar; 19(3):894-906. PubMed ID: 30582270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Belatacept during pregnancy in renal transplant recipients: Two case reports.
    Combs J; Kagan A; Boelkins M; Coscia L; Moritz M; Hofmann RM
    Am J Transplant; 2018 Aug; 18(8):2079-2082. PubMed ID: 29719109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immunosuppression improves early allograft function in a porcine kidney transplant model of donation after circulatory death.
    Xu M; Garcia-Aroz S; Banan B; Wang X; Rabe BJ; Zhou F; Nayak DK; Zhang Z; Jia J; Upadhya GA; Manning PT; Gaut JP; Lin Y; Chapman WC
    Am J Transplant; 2019 Mar; 19(3):713-723. PubMed ID: 30152136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.
    Xu H; Samy KP; Guasch A; Mead SI; Ghali A; Mehta A; Stempora L; Kirk AD
    Am J Transplant; 2016 Feb; 16(2):550-64. PubMed ID: 26436448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe Conversion From Tacrolimus to Belatacept in High Immunologic Risk Kidney Transplant Recipients With Allograft Dysfunction.
    Gupta G; Regmi A; Kumar D; Posner S; Posner MP; Sharma A; Cotterell A; Bhati CS; Kimball P; Massey HD; King AL
    Am J Transplant; 2015 Oct; 15(10):2726-31. PubMed ID: 25988397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo belatacept in clinical vascularized composite allotransplantation.
    Cendales LC; Ruch DS; Cardones AR; Potter G; Dooley J; Dore D; Orr J; Ruskin G; Song M; Chen DF; Selim MA; Kirk AD
    Am J Transplant; 2018 Jul; 18(7):1804-1809. PubMed ID: 29723921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts.
    Sparkes T; Ravichandran B; Opara O; Ugarte R; Drachenberg CB; Philosophe B; Bromberg JS; Barth RN
    Clin Transplant; 2019 Jun; 33(6):e13531. PubMed ID: 30866104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete Regression of Psoriatic Arthritis After Belatacept Conversion in a Highly HLA-Sensitized Kidney Transplant Patient.
    Meneghini M; Gómez C; Mast R; Melilli E; Grinyó JM; Bestard O
    Am J Transplant; 2017 May; 17(5):1409-1413. PubMed ID: 27996207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized, noninferiority trial.
    Badell IR; Parsons RF; Karadkhele G; Cristea O; Mead S; Thomas S; Robertson JM; Kim GS; Hanfelt JJ; Pastan SO; Larsen CP
    Am J Transplant; 2021 Sep; 21(9):3066-3076. PubMed ID: 33583120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
    Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
    Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept.
    Karadkhele G; Hogan J; Magua W; Zhang W; Badell IR; Mehta A; Lyon M; Pastan S; Pearson TC; Larsen CP
    Am J Transplant; 2021 Jan; 21(1):208-221. PubMed ID: 32519434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.